MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, AGIO has $1,184,990K in assets. $75,875K in debts. $113,600K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1418.72%
Quick Ratio
1359.09%
Cash Ratio
193.05%
Debt to Asset Ratio
6.40%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Marketable securities
    • Operating lease assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Treasury stock, at cost (16,216,...
    • Accumulated deficit
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
113,600 89,130 92,710 80,871
Marketable securities
623,438 765,295 860,150 858,066
Accounts receivable, net
16,132 10,577 5,029 4,986
Inventory
35,087 32,920 32,034 30,848
Prepaid expenses and other current assets
46,586 44,130 43,186 44,693
Total current assets
834,843 942,052 1,033,109 1,019,464
Marketable securities
308,454 310,013 304,341 400,467
Operating lease assets
27,196 30,454 33,650 36,785
Property and equipment, net
10,566 10,775 10,675 10,579
Other non-current assets
3,931 3,931 3,930 3,942
Total assets
1,184,990 1,297,225 1,385,705 1,471,237
Accounts payable
13,747 18,355 19,553 17,532
Accrued expenses
26,293 45,459 37,217 35,289
Income taxes payable
-0 0 0
Operating lease liabilities
18,805 18,392 17,987 17,589
Total current liabilities
58,845 82,206 74,757 70,410
Operating lease liabilities, net of current portion
16,940 21,815 26,528 31,171
Other non-current liabilities
90 90 90 101
Total liabilities
75,875 104,111 101,375 101,682
Common stock, 0.001 par value 125,000,000 shares authorized 75,557,749 shares issued and 59,341,338 outstanding at march31, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at december31, 2025
76 75 74 74
Additional paid-in capital
2,572,655 2,555,037 2,538,357 2,521,545
Accumulated other comprehensive (loss) income
-314 2,193 2,051 655
Accumulated deficit
-660,816 -561,705 -453,666 -350,233
Treasury stock, at cost (16,216,411 shares at march31, 2026 and december31, 2025)
802,486 802,486 802,486 802,486
Total stockholders equity
1,109,115 1,193,114 1,284,330 1,369,555
Total liabilities and stockholders equity
1,184,990 1,297,225 1,385,705 1,471,237
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$623,438K Cash and cashequivalents$113,600K Prepaid expenses andother current assets$46,586K Inventory$35,087K Accounts receivable, net$16,132K Total current assets$834,843K Marketable securities$308,454K Operating lease assets$27,196K Property and equipment,net$10,566K Other non-currentassets$3,931K Total assets$1,184,990K Total liabilities andstockholders equity$1,184,990K Total stockholdersequity$1,109,115K Total liabilities$75,875K Treasury stock, at cost(16,216,411 shares at...$802,486K Accumulated deficit-$660,816K Accumulated othercomprehensive (loss) income-$314K Additional paid-in capital$2,572,655K Total currentliabilities$58,845K Operating leaseliabilities, net of current...$16,940K Other non-currentliabilities$90K Common stock, 0.001 parvalue 125,000,000...$76K Accrued expenses$26,293K Operating leaseliabilities$18,805K Accounts payable$13,747K

AGIOS PHARMACEUTICALS, INC. (AGIO)

AGIOS PHARMACEUTICALS, INC. (AGIO)